CORE--HUMAN CHALLENGE FACILITY

$157,141U19FY2000AINIH

University Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications & trials

Paper 30399091 Paper 30073599 Paper 29752412 Paper 29697553 Paper 29342269 Paper 28585815 Paper 27631353 Paper 27353397 Paper 27305908 Paper 27224979 Paper 27216061 Paper 27100769 Paper 26812077 Paper 26562811 Paper 26351283 Paper 26229069 Paper 26040011 Paper 25907334 Paper 25897604 Paper 25863467 Paper 25701234 Paper 25668649 Paper 25546329 Paper 25367915 Paper 24982323 Paper 24844153 Paper 24837286 Paper 24825334 Paper 24820072 Paper 24733458 Paper 24702589 Paper 24695013 Paper 24686069 Paper 24255126 Paper 24243883 Paper 24126526 Paper 24042118 Paper 24016806 Paper 24002068 Paper 23945503 Paper 23836816 Paper 23677018 Paper 23633669 Paper 23506248 Paper 23462098 Paper 23321990 Paper 23221802 Paper 23220780 Paper 23071134 Paper 22957710 Paper 22949553 Paper 22902666 Paper 22902662 Paper 22844448 Paper 22614898 Paper 22492860 Paper 22399131 Paper 22239555 Paper 22214775 Paper 22183845 Paper 22087340 Paper 21947770 Paper 21937985 Paper 21933917 Paper 21856514 Paper 21747812 Paper 21747807 Paper 21747781 Paper 21734909 Paper 21502084 Paper 21370602 Paper 21288838 Paper 21245268 Paper 21041493 Paper 20705160 Paper 20687840 Paper 20625928 Paper 20439477 Paper 20107432 Paper 20075243 Paper 19956622 Paper 19913149 Paper 19556926 Paper 19455082 Paper 19414800 Paper 19015257 Paper 18762223 Paper 18761689 Paper 18614609 Paper 18541655 Paper 18490867 Paper 18212073 Paper 18157061 Paper 18090052 Paper 18028581 Paper 17763335 Paper 17690570 Paper 17578778 Paper 17542928 Paper 17326860

Abstract

The Human Challenge Core is available to assess the infectiousness of Neisseria gonorrhoeae isogenic mutants developed in this application, or mutants generated by investigators at other CRCs. Specifically, we will examine the requirements for heme and hemoglobin receptors, and requirement for opa proteins. In addition, the Core will test gonococcal isolates that have already been developed as part of the CRC Program. Specifically, mutants less likely to resist the microbicidal action of the neutrophil inflammatory response have been generated. The Core can also support vaccine research, if a vaccine with adequate immunogenicity is developed. Core facilities include the Microbiology laboratory in the Division of Infectious Disease, and the patient care areas of the General research Center.

View original record on NIH RePORTER →